CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a prospective, open-label, multi-cohort, non-randomized, multicenter phase 2 study evaluating LN-145 in patients with metastatic non...
Phase 2
Cincinnati, Ohio, United States and 43 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
Kettering, Ohio, United States and 33 other locations
Non-Squamous Non-Small Cell Lung Cancer (NSCLC) remains a leading cause of cancer mort...
Phase 2, Phase 3
Cincinnati, Ohio, United States and 22 other locations
PDCT in participants with previously untreated Stage IV or recurrent non-small cell lung cancer (NSCLC)....
Phase 2
Cincinnati, Ohio, United States and 126 other locations
participants with unresectable or metastatic melanoma or advanced non-small-cell lung cancer (NSCLC)....
Phase 1, Phase 2
Cincinnati, Ohio, United States and 8 other locations
A study to assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung...
Phase 2
Blue Ash, Ohio, United States and 137 other locations
NSCLC comprises of approximately 84 percent (%) of all lung cancers and is often diagnosed at advanced stage due to poor prognosis....
Phase 2
Cincinnati, Ohio, United States and 57 other locations
This is a multicenter, randomized, open-label study of Tumor Treating Fields (TTFields) at 150 kHz to the thorax using the NovoTTF-200T Syst-...
Phase 2
Edgewood, Kentucky, United States and 23 other locations
This Phase 3 study will evaluate the efficacy of the investigational agent MRTX849 (adagrasib) versus docetaxel in patients who have been previously...
Phase 3
Kettering, Ohio, United States and 262 other locations
in previously untreated patients with locally advanced or metastatic non-squamous Non-Small Cell Lung Ca...
Phase 3
Cincinnati, Ohio, United States and 206 other locations
Clinical trials
Research sites
Resources
Legal